Skip to main content

Table 2 A-C All statistically significant ARGs that are enriched after oral treatment with Ampicillin (A), Ciprofloxacin (B), or Fosfomycin (C)

From: The effect of antibiotics on the gut microbiome: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice

ARGIncrease/Decrease
24 h48 h72 h
A. Ampicillin
 efrB+
 LlmA 23S ribosomal RNA methyltransferase+
 macB+
 mupA+
 mupB+
 patB+
 Streptomyces rishiriensis parY mutant conferring resistance to aminocoumarin+
 tetB(46)+
 tetB(60)++
B. Ciprofloxacin
 ANT(6)-Ib+
 arlR++
 Bifidobacterium adolescentis rpoB conferring resistance to rifampicin++
 cepA beta-lactamase++
 cmeB+
 efrA+
 efrB++
 lsaB+
 macB+
 mupA++
 Nocardia rifampin resistant beta-subunit of RNA polymerase (rpoB2)+++
 Streptomyces rishiriensis parY mutant conferring resistance to aminocoumarin+
 TaeA+
 tet(W/N/W)+
 tetA(60)++
 tetB(P)+
 tetM+
 tetW+
 ugd+
 vanRC++
 vanRG+
 vanRI+
 vanSC+
 vanWG+
 vanYG1+
C. Fosfomycin
 ANT(6)-Ib++
 Bifidobacteria intrinsic ileS conferring resistance to mupirocin+
 catB10+
 cepA beta-lactamase+++
 cmeB+++
 macB+
 msbA+++
 mupB+++
 Nocardia rifampin resistant beta-subunit of RNA polymerase (rpoB2)++
 TaeA++
 tet37+++
 ugd+++
  1. For each antibiotic cohort, all bacterial ARGs with a statistically significant increase in relative abundance at any timepoints are listed in tabular form. Plus sign in the column for a timepoint indicates that the ARG count increased after administering treatment at that timepoint and a minus sign indicates a decrease in the count